The DOI matches its Crossref record; 95 of the 95 references it cites were found in a registry or an index.
Developmental Changes in Pharmacokinetics and Pharmacodynamics
Open accessAbstract
Effective drug therapy to optimally influence disease requires an understanding of a drug's pharmacokinetic, pharmacodynamic, and pharmacogenomic interrelationships. In pediatrics, age is a continuum that can and does add variability in drug disposition and effect. This article addresses the many important factors that influence drug disposition and effect relative to age. What is known about the influence of maturation on the processes of drug absorption, distribution, metabolism, excretion, and drug receptor dynamics are outlined. Our state of understanding of many of these factors remains in flux, however, and only with additional study will we be able to better anticipate and model drug‐response relationships across the age continuum. Being able to continuously improve our care of the ill pediatric patient while simultaneously being able to accurately determine the utility of new drugs and chemical entities in this population requires our enhanced understanding of these disposition characteristics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Insights into the regulation of protein abundance from proteomic and transcriptomic analyses
Vogel, C., & Marcotte, E. M. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3185 · Cited by 4,195
Developmental Pharmacology — Drug Disposition, Action, and Therapy in Infants and Children
Kearns, G. L., Abdel-Rahman, S. M., Alander, S. W., Blowey, D. L., Leeder, J. S., & Kauffman, R. E. (2003) · New England Journal of Medicine · doi:10.1056/nejmra035092 · Cited by 2,421
Self-citationSchwartz, G. J., Brion, L. P., & Spitzer, A. (1987) · Pediatric Clinics of North America · doi:10.1016/s0031-3955(16)36251-4 · Cited by 1,726
(1965) · Archives of Disease in Childhood · doi:10.1136/adc.40.211.338 · Cited by 821
Cytochrome P450 3A: Ontogeny and Drug Disposition
de Wildt, S. N., Kearns, G. L., Leeder, J. S., & van den Anker, J. N. (1999) · Clinical Pharmacokinetics · doi:10.2165/00003088-199937060-00004 · Cited by 586
Self-citationBartelink, I. H., Rademaker, C. M. A., Schobben, A. F. A. M., & van den Anker, J. N. (2006) · Clinical Pharmacokinetics · doi:10.2165/00003088-200645110-00003 · Cited by 418
Self-citationThe ontogeny of drug metabolism enzymes and implications for adverse drug events
Hines, R. N. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2008.02.005 · Cited by 410
Impact of Obesity on Drug Metabolism and Elimination in Adults and Children
Brill, M. J. E., Diepstraten, J., van Rongen, A., van Kralingen, S., van den Anker, J. N., & Knibbe, C. A. J. (2012) · Clinical Pharmacokinetics · doi:10.2165/11599410-000000000-00000 · Cited by 382
Self-citationDevelopmental changes and polymorphism in human alcohol dehydrogenase
SMITH, M., HOPKINSON, D. A., & HARRIS, H. (1971) · Annals of Human Genetics · doi:10.1111/j.1469-1809.1971.tb00238.x · Cited by 369
Developmental Pharmacokinetics in Pediatric Populations
Lu, H., & Rosenbaum, S. (2014) · The Journal of Pediatric Pharmacology and Therapeutics · doi:10.5863/1551-6776-19.4.262 · Cited by 358
Paediatric pharmacokinetics: key considerations
Batchelor, H. K., & Marriott, J. F. (2015) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12267 · Cited by 355
Intestinal drug transporters: An overview
Estudante, M., Morais, J. G., Soveral, G., & Benet, L. Z. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.042 · Cited by 330
The Clinical Relevance of Plasma Protein Binding Changes
Roberts, J. A., Pea, F., & Lipman, J. (2013) · Clinical Pharmacokinetics · doi:10.1007/s40262-012-0018-5 · Cited by 329
Developmental aspects of human hepatic drug glucuronidation in young children and adults
Strassburg, C. P., Strassburg, A., Kneip, S., Barut, A., Tukey, R. H., Rodeck, B., & Manns, M. P. (2002) · Gut · doi:10.1136/gut.50.2.259 · Cited by 288
Ontogeny of human hepatic cytochromes P450
Hines, R. N. (2007) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.20179 · Cited by 276
Ward, R. M., & Kearns, G. L. (2013) · Pediatric Drugs · doi:10.1007/s40272-013-0012-x · Cited by 202
Self-citationAnderson, B. J., Woollard, G. A., & Holford, N. H. G. (2000) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2000.00231.x · Cited by 194
Court, M. H., Zhang, X., Ding, X., Yee, K. K., Hesse, L. M., & Finel, M. (2012) · Xenobiotica · doi:10.3109/00498254.2011.618954 · Cited by 193
Hines, R. N. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.05.079 · Cited by 190
Fatal Cardiovascular Collapse of Infants Receiving Large Amounts of Chloramphenicol
SUTHERLAND, J. M. (1959) · Archives of Pediatrics & Adolescent Medicine · doi:10.1001/archpedi.1959.02070010763001 · Cited by 189
Ontogeny of Dextromethorphan O- and N-demethylation in the First Year of Life
Blake, M. J., Gaedigk, A., Pearce, R. E., Bomgaars, L. R., Christensen, M. L., Stowe, C., James, L. P., Wilson, J. T., Kearns, G. L., & Leeder, J. S. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100101 · Cited by 169
Self-citationOntogeny of Human Hepatic and Intestinal Transporter Gene Expression during Childhood: Age Matters
Mooij, M. G., Schwarz, U. I., de Koning, B. A. E., Leeder, J. S., Gaedigk, R., Samsom, J. N., Spaans, E., van Goudoever, J. B., Tibboel, D., Kim, R. B., et al. (2014) · Drug Metabolism and Disposition · doi:10.1124/dmd.114.056929 · Cited by 164
LOCALIZATION AND mRNA EXPRESSION OF CYP3A AND P-GLYCOPROTEIN IN HUMAN DUODENUM AS A FUNCTION OF AGE
Fakhoury, M., Litalien, C., Médard, Y., Cavé, H., Ezzahir, N., Peuchmaur, M. M., & Jacqz-Aigrain, É. (2005) · Drug Metabolism and Disposition · doi:10.1124/dmd.105.005611 · Cited by 155
Maturation and growth of renal function: Dosing renally cleared drugs in children
Hayton, W. L. (2000) · AAPS PharmSci · doi:10.1208/ps020103 · Cited by 148
Miki, Y., Suzuki, T., Tazawa, C., Blumberg, B., & Sasano, H. (2005) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2004.12.005 · Cited by 145
Paediatric oral biopharmaceutics: Key considerations and current challenges
Batchelor, H. K., Fotaki, N., & Klein, S. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.10.006 · Cited by 142
Friis-Hansen, B. (1971) · PubMed · Cited by 141
Pathophysiological and Disease-Induced Changes in Drug Distribution Volume
Klotz, U. E. (1976) · Clinical Pharmacokinetics · doi:10.2165/00003088-197601030-00003 · Cited by 106
Nicolas, J., Bouzom, F., Chanteux, H., & Ungell, A.-L. B. (2016) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.2052 · Cited by 104
Up-Regulation of Glutathione S-Transferase Activity in Enterocytes of Young Children
Gibbs, J. P., Liacouras, C. A., Baldassano, R. N., & Slattery, J. T. (1999) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)14957-4 · Cited by 100
Age-mediated changes in the gastrointestinal tract
Merchant, H. A., Liu, F., Orlu, M., & Basit, A. W. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2016.04.024 · Cited by 99
Cock, R. F. W. D., Allegaert, K., Brussee, J. M., Sherwin, C. M. T., Mulla, H., de Hoog, M., van den Anker, J. N., Danhof, M., & Knibbe, C. A. J. (2014) · Pharmaceutical Research · doi:10.1007/s11095-014-1361-z · Cited by 98
Self-citationThe Development of UDP-Glucuronosyltransferases 1A1 and 1A6 in the Pediatric Liver
Miyagi, S. J., & Collier, A. C. (2011) · Drug Metabolism and Disposition · doi:10.1124/dmd.110.037192 · Cited by 96
Developmental Pharmacokinetics
van den Anker, J. N., Schwab, M. G., & Kearns, G. L. (2011) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-20195-0_2 · Cited by 94
Self-citationNeonatal drug therapy: The first frontier of therapeutics for children
Allegaert, K., & van den Anker, J. N. (2015) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.166 · Cited by 92
Self-citationEffect of Diet on the Development of Drug Metabolism by Cytochrome P-450 Enzymes in Healthy Infants
Blake, M. J., Abdel‐Rahman, S. M., Pearce, R. E., Leeder, J. S., & Kearns, G. L. (2006) · Pediatric Research · doi:10.1203/01.pdr.0000245909.74166.00 · Cited by 87
Self-citationPharmacokinetics of single dose intravenous propacetamol in neonates: effect of gestational age
Allegaert, K., der Marel, C. D. V., Debeer, A., Pluim, M. A. L., Lingen, R. A. V., Vanhole, C., Tibboel, D., & Devlieger, H. (2004) · Archives of Disease in Childhood Fetal & Neonatal · doi:10.1136/fn.89.1.f25 · Cited by 87
Self-citationQuantitative pupillometry: normative data in healthy pediatric volunteers
Boev, A. N., Fountas, K. N., Karampelas, I. H., Boev, C., Machinis, T. G., Feltes, C. H., Okosun, I. S., Dimopoulos, V. G., & Troup, C. (2005) · Journal of neurosurgery · doi:10.3171/ped.2005.103.6.0496 · Cited by 86
Cytochrome P450 3A and 2B6 in the developing kidney: implications for ifosfamide nephrotoxicity
Aleksa, K., Matsell, D. G., Krausz, K., Gelboin, H. V., Ito, S., & Koren, G. (2005) · Pediatric Nephrology · doi:10.1007/s00467-004-1807-3 · Cited by 82
Wilbaux, M., Fuchs, A., Samardžić, J., Rodieux, F., Csajka, C., Allegaert, K., van den Anker, J. N., & Pfister, M. (2016) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.705 · Cited by 81
Self-citationClinical Pharmacology Studies in Critically Ill Children
Thakkar, N., Salerno, S. N., Hornik, C. P. V., & González, D. (2016) · Pharmaceutical Research · doi:10.1007/s11095-016-2033-y · Cited by 80
Development and applications of a physiologically-based model of paediatric oral drug absorption
Johnson, T. N., Bonner, J. J., Tucker, G. T., Turner, D. B., & Jamei, M. (2018) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2018.01.009 · Cited by 77
Yu, G., Zheng, Q., & Li, G. (2014) · The AAPS Journal · doi:10.1208/s12248-014-9652-1 · Cited by 76
Holford, N. H. G. (2010) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2009.262 · Cited by 74
Pharmacological research in pediatrics: From neonates to adolescents☆
Rakhmanina, N. Y., & VANDENANKER, J. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.12.001 · Cited by 74
Self-citationCisapride disposition in neonates and infants: in vivo reflection of cytochrome P450 3A4 ontogeny
Kearns, G. L., Robinson, P. K., Wilson, J. T., Wilson-Costello, D., Knight, G. R., Ward, R. M., & van den Anker, J. N. (2003) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(03)00225-x · Cited by 74
Self-citationSchaefer, F. S., Walle, J. V., Zurowska, A. M., Gimpel, C., Hoeck, K. V., Drożdż, D., Montini, G., Bagdasorova, I. V., Sorof, J. M., Sugg, J. E., et al. (2010) · Journal of Hypertension · doi:10.1097/hjh.0b013e328336b86b · Cited by 72
Development of Human Membrane Transporters: Drug Disposition and Pharmacogenetics
Mooij, M. G., Nies, A. T., Knibbe, C. A. J., Schaeffeler, E., Tibboel, D., Schwab, M. G., & de Wildt, S. N. (2015) · Clinical Pharmacokinetics · doi:10.1007/s40262-015-0328-5 · Cited by 72
Understanding Developmental Pharmacodynamics: Importance for Drug Development and Clinical Practice
Mulla, H. (2010) · Pediatric Drugs · doi:10.2165/11319220-000000000-00000 · Cited by 68
Single dose, CYP2D6 genotype‐stratified pharmacokinetic study of atomoxetine in children with ADHD
Brown, J., ABDELRAHMAN, S., van Haandel, L., Gaedigk, A., Lin, Y., & Leeder, J. S. (2015) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.319 · Cited by 68
Allegaert, K., van Schaik, R. H. N., Vermeersch, S., Verbesselt, R., Cossey, V., Vanhole, C., van Fessem, M., Hoon, J. N. J. M. D., & van den Anker, J. N. (2008) · Pediatric Research · doi:10.1203/pdr.0b013e31816ff712 · Cited by 64
Self-citationPerinatal and neonatal use of paracetamol for pain relief
Allegaert, K., & van den Anker, J. N. (2017) · Seminars in Fetal and Neonatal Medicine · doi:10.1016/j.siny.2017.07.006 · Cited by 62
Self-citationCaffeine Citrate Dosing Adjustments to Assure Stable Caffeine Concentrations in Preterm Neonates
Koch, G., Datta, A., Jost, K., Schulzke, S. M., van den Anker, J. N., & Pfister, M. (2017) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2017.08.064 · Cited by 59
Cook, S. F., Roberts, J. K., Samiee‐Zafarghandy, S., Stockmann, C. R., King, A. D., Deutsch, N., Williams, E. F., Allegaert, K., Wilkins, D. G., Sherwin, C. M. T., et al. (2015) · Clinical Pharmacokinetics · doi:10.1007/s40262-015-0301-3 · Cited by 57
Self-citationDevelopmental Pharmacokinetics in Neonates: Maturational Changes and Beyond
Allegaert, K., Mian, P., & van den Anker, J. N. (2017) · Current Pharmaceutical Design · doi:10.2174/1381612823666170926121124 · Cited by 55
Self-citationTakashima, T., Yokoyama, C., Mizuma, H., Yamanaka, H., Wada, Y., Onoe, K., Nagata, H., Tazawa, S., Doi, H., Takahashi, K., et al. (2011) · Journal of Nuclear Medicine · doi:10.2967/jnumed.110.083949 · Cited by 53
Cook, S. F., Stockmann, C. R., Samiee‐Zafarghandy, S., King, A. D., Deutsch, N., Williams, E. F., Wilkins, D. G., Sherwin, C. M. T., & van den Anker, J. N. (2016) · Clinical Pharmacokinetics · doi:10.1007/s40262-016-0408-1 · Cited by 53
Wolf, G. K., McClain, C. D., Zurakowski, D., Dodson, B. L., & McManus, M. L. (2006) · Pediatric Critical Care Medicine · doi:10.1097/01.pcc.0000235252.43921.de · Cited by 52
Neonatal Development of Hepatic UGT1A9: Implications of Pediatric Pharmacokinetics
Miyagi, S. J., Milne, A., Coughtrie, M. W. H., & Collier, A. C. (2012) · Drug Metabolism and Disposition · doi:10.1124/dmd.111.043752 · Cited by 52
Factors impacting unbound vancomycin concentrations in neonates and young infants
Smits, A., Pauwels, S., Oyaert, M., Peersman, N., Spriet, I., Saegeman, V., & Allegaert, K. (2018) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-018-3277-8 · Cited by 52
Self-citationPopulation pharmacokinetics of midazolam and its metabolites in overweight and obese adolescents
van Rongen, A., Vaughns, J. D., Moorthy, G. S., Barrett, J. S., Knibbe, C. A. J., & van den Anker, J. N. (2015) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12693 · Cited by 51
Ince, I., de Wildt, S. N., Wang, C., Peeters, M. Y. M., Burggraaf, J., Jacqz-Aigrain, É., van den Anker, J. N., Tibboel, D., Danhof, M., & Knibbe, C. A. J. (2013) · Clinical Pharmacokinetics · doi:10.1007/s40262-013-0050-0 · Cited by 51
Critical Illness Is a Major Determinant of Midazolam Clearance in Children Aged 1 Month to 17 Years
Ince, I., de Wildt, S. N., Peeters, M. Y. M., Murry, D. J., Tibboel, D., Danhof, M., & Knibbe, C. A. J. (2012) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0b013e31825a4c3a · Cited by 48
Effects of Valproic Acid on Organic Acid Metabolism in Children: A Metabolic Profiling Study
Price, K., Pearce, R., Garg, U., Heese, B. A., Smith, L. D., Sullivan, J., Kennedy, M. J., Bale, J., Ward, R. M., Chang, T., et al. (2011) · Clinical pharmacology and therapy · doi:10.1038/clpt.2011.47 · Cited by 45
Evidence-based drug treatment for special patient populations through model-based approaches
Krekels, E. H. J., van Hasselt, J. G. C., van den Anker, J. N., Allegaert, K., Tibboel, D., & Knibbe, C. A. J. (2017) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2017.05.022 · Cited by 45
Self-citationMaharaj, A. R., & Edginton, A. N. (2016) · Drug Metabolism and Disposition · doi:10.1124/dmd.115.068700 · Cited by 44
Chen, Y.-T., Trzoss, L., Yang, D., & Yan, B. (2015) · Toxicology · doi:10.1016/j.tox.2015.02.007 · Cited by 41
Brussee, J. M., Vet, N. J., Krekels, E. H. J., Valkenburg, A. J., Jacqz-Aigrain, É., van Gerven, J., Swart, E. L., van den Anker, J. N., Tibboel, D., de Hoog, M., et al. (2017) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.13459 · Cited by 41
First‐Pass CYP3A‐Mediated Metabolism of Midazolam in the Gut Wall and Liver in Preterm Neonates
Brussee, J. M., Yu, H., Krekels, E. H. J., de Roos, B., Brill, M. J. E., van den Anker, J. N., Rostami‐Hodjegan, A., de Wildt, S. N., & Knibbe, C. A. J. (2018) · CPT Pharmacometrics & Systems Pharmacology · doi:10.1002/psp4.12295 · Cited by 40
Salem, A. H., Fletcher, C. V., & Brundage, R. C. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01738-13 · Cited by 39
Losartan attenuates symptomatic and hormonal responses to hypoglycemia in humans
Deininger, E., Oltmanns, K. M., Wellhoener, P., Fruehwald‐Schultes, B., Kern, W., Heuer, B., Dominiak, P., Jan Born, A., Fehm, H. L., & Peters, A. (2001) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(01)26448-0 · Cited by 38
Wildschut, E. D., van Saet, A., Pokorná, P., Ahsman, M. J., van den Anker, J. N., & Tibboel, D. (2012) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2012.07.013 · Cited by 33
Population Pharmacokinetics of Amoxicillin in Term Neonates Undergoing Moderate Hypothermia
Bijleveld, Y. A., Mathôt, R. A. A., van der Lee, J. H., Groenendaal, F., Dijk, P. H., van Heijst, A. F. J., Simons, S. H. P., Dijkman, K. P., van Straaten, H., Rijken, M., et al. (2017) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.748 · Cited by 28
Dinh, J., Pearce, R. E., van Haandel, L., Gaedigk, A., & Leeder, J. S. (2016) · Drug Metabolism and Disposition · doi:10.1124/dmd.116.069518 · Cited by 27
Protein Binding of Flucloxacillin in Neonates
Pullen, J., Stolk, L. M., Degraeuwe, P. L. J., van Tiel, F. H., Neef, C., & Zimmermann, L. J. I. (2007) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0b013e318063e30f · Cited by 26
Steady state serum concentrations and renal clearance of digoxin in neonates, infants and children
Halkin, H., Radomsky, M. L., Millman, P., Almog, S., Blieden, L. C., & Boichis, H. (1978) · European Journal of Clinical Pharmacology · doi:10.1007/bf00609754 · Cited by 25
P-glycoprotein in the Developing Human Brain
Lam, J., & Koren, G. (2014) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0000000000000087 · Cited by 24
Rogers, Z., Hiruy, H., Pasipanodya, J. G., Mbowane, C., Adamson, J., Ngotho, L., Karim, F., Jeena, P. M., Bishai, W. R., & Gumbo, T. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.07.031 · Cited by 24
Single time point diagnostic breath tests: a review
Modak, A. S. (2009) · Journal of Breath Research · doi:10.1088/1752-7155/4/1/017002 · Cited by 22
Barbosa-Cortés, L., Vera, H., Morán, S., Prado, M. D., & López-Alarcón, M. (2005) · Nutrition · doi:10.1016/j.nut.2004.05.027 · Cited by 22
Thelingwani, R., Dhansay, K., Smith, P. J., Chibale, K., & Masimirembwa, C. (2012) · Xenobiotica; the fate of foreign compounds in biological systems · doi:10.3109/00498254.2012.681077 · Cited by 22
Funk, R. S., Chan, M. A., & Becker, M. L. (2017) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1938 · Cited by 22
Allegaert, K., Pauwels, S., Smits, A., Crèvecoeur, K., van den Anker, J., Mekahli, D., & Vermeersch, P. (2014) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2013-1035 · Cited by 21
Self-citationEffect of hypothermia and extracorporeal life support on drug disposition in neonates
Wildschut, E. D., de Wildt, S. N., Mathôt, R. A. A., Reiss, I. K. M., Tibboel, D., & van den Anker, J. N. (2012) · Seminars in Fetal and Neonatal Medicine · doi:10.1016/j.siny.2012.10.002 · Cited by 15
Zhiyuan, Q., Li, Q., Sheng-ming, H., & Ma, H. (2016) · Brain Injury · doi:10.3109/02699052.2015.1080386 · Cited by 15
Kearns, G. L., & Artman, M. (2015) · Current Pharmaceutical Design · doi:10.2174/1381612821666150901105337 · Cited by 15
Self-citationJones, B. L., Abdel‐Rahman, S. M., Simon, S. D., Kearns, G. L., & Neville, K. A. (2009) · The Journal of Clinical Pharmacology · doi:10.1177/0091270009332247 · Cited by 14
Self-citationSeverity of asphyxia is a covariate of phenobarbital clearance in newborns undergoing hypothermia
Pokorná, P., Posch, L., Šíma, M., Klement, P., Slanař, O., van den Anker, J. N., Tibboel, D., & Allegaert, K. (2018) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2018.1432039 · Cited by 14
Self-citationUrinary Biomarkers of Trimethoprim Bioactivation in Vivo Following Therapeutic Dosing in Children
van Haandel, L., Goldman, J. L., Pearce, R. E., & Leeder, J. S. (2013) · Chemical Research in Toxicology · doi:10.1021/tx4003325 · Cited by 13
Population Pharmacokinetics of Theophylline in Premature Korean Infants
Kim, S. E., Kim, B., Lee, S., Sohn, J. A., Kim, H., Cho, J., Yoon, S. H., Jang, I., Yu, K., & Lim, K. S. (2013) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0b013e3182866695 · Cited by 12
Insufficient ketoconazole concentrations in preterm infants with fungal infections
van den Anker, J. N., van Lingen, R. A., Koster, M., Heykants, J. J. P., & Sauer, P. J. J. (1993) · European Journal of Pediatrics · doi:10.1007/bf01955070 · Cited by 11
Variability of Histamine Pharmacodynamic Response in Children With Allergic Rhinitis
Jones, B. L., Kearns, G. L., Neville, K. A., Sherwin, C. M. T., Spigarelli, M. G., & Leeder, J. S. (2013) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.93 · Cited by 10
Self-citationMethod for predicting human intestinal first-pass metabolism of UGT substrate compounds
Furukawa, T. Y., Yamano, K., Naritomi, Y., Tanaka, K., Terashita, S., & Teramura, T. (2012) · Xenobiotica · doi:10.3109/00498254.2012.680620 · Cited by 10
Pharmacokinetics and pharmacodynamics of intravenous acetaminophen in neonates
Allegaert, K., & van den Anker, J. (2011) · Expert Review of Clinical Pharmacology · doi:10.1586/ecp.11.50 · Cited by 9
Self-citationKielbasa, W., & Lobo, E. D. (2015) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.551 · Cited by 8
Cited by
Vinarov, Z., Abdallah, M., Agundez, J. A. G., Allegaert, K., Basit, A. W., Braeckmans, M., Ceulemans, J., Corsetti, M., Griffin, B. T., Grimm, M., et al. (2021) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2021.105812 · Cited by 359
Self-citationLin, W., Chen, Y., Unadkat, J. D., Zhang, X., Wu, D., & Heimbach, T. (2022) · Pharmaceutical Research · doi:10.1007/s11095-022-03274-2 · Cited by 137
Sun, Z., Zhao, N., Zhao, X., Wang, Z., Liu, Z., & Cui, Y. (2024) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2024.106838 · Cited by 65
Smits, A., Annaert, P., Cavallaro, G., De Cock, P. A. J. G., de Wildt, S. N., Kindblom, J. M., Lagler, F. B., Moreno, C., Pokorna, P., Schreuder, M. F., et al. (2022) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.14958 · Cited by 55
Self-citation
Metadata
- Authors
- van den Anker, J., Reed, M. D., Allegaert, K., & Kearns, G. L.
- Venue
- The Journal of Clinical Pharmacology
- Publisher
- Wiley
- Published
- 2018-09-24
- Volume
- 58
- Issue
- S10
- Pages
- S10-S25
- ISSN
- 0021-9754 (ISSN-L)
- 0091-2700
- 1552-4604
- OpenAlex
- W2893814358
- Cited by
- 389
- References
- 95
- FWCI
- 22.57
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.